Cramp911 Lotion
NDC Package 35484-924-04
Package Information
Cramp911 (magnesium sulfate, copper sulfate) lotions is classified as a
- calculi dissolution agent - [epc] (established pharmacologic class)
- copper - [cs]
- copper-containing intrauterine device - [epc] (established pharmacologic class)
- decreased embryonic implantation - [pe] (physiologic effect)
- decreased sperm motility - [pe] (physiologic effect)
- increased large intestinal motility - [pe] (physiologic effect)
- inhibit ovum fertilization - [pe] (physiologic effect)
- inhibition large intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- inhibition small intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- magnesium ion exchange activity - [moa] (mechanism of action)
- osmotic activity - [moa] (mechanism of action)
- osmotic laxative - [epc] (established pharmacologic class)
- stimulation large intestine fluid/electrolyte secretion - [pe] (physiologic effect)
- calculi dissolution agent - [epc] (established pharmacologic class)
- copper - [cs]
- copper-containing intrauterine device - [epc] (established pharmacologic class)
- decreased embryonic implantation - [pe] (physiologic effect)
- decreased sperm motility - [pe] (physiologic effect)
- increased large intestinal motility - [pe] (physiologic effect)
- inhibit ovum fertilization - [pe] (physiologic effect)
- inhibition large intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- inhibition small intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- magnesium ion exchange activity - [moa] (mechanism of action)
- osmotic activity - [moa] (mechanism of action)
- osmotic laxative - [epc] (established pharmacologic class)
- stimulation large intestine fluid/electrolyte secretion - [pe] (physiologic effect)
Identification & Billing
Clinical Specifications
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 35484 - Delcorean, Llc
- 35484-924 - Cramp911
- 35484-924-04 - 1 BOTTLE, WITH APPLICATOR in 1 CARTON / 4.5 mL in 1 BOTTLE, WITH APPLICATOR
- 35484-924 - Cramp911
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (35484-924). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 35484-924-04 identifies a specific commercial package of 1 bottle, with applicator in 1 carton / 4.5 ml in 1 bottle, with applicator of Cramp911, a human over the counter drug labeled by Delcorean, Llc. This lotion is formulated for topical use and contains basic copper sulfate; magnesium sulfate, unspecified form as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Delcorean, Llc on September 01, 2008. The current certification is valid through December 31, 2027.
How is this Delcorean, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 35484092404. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.